Image 2_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.tif
Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. Immunotherapy combined with chemotherapy has emerged as a promising approach; however, its e...
محفوظ في:
| المؤلف الرئيسي: | Hua Ruan (195072) (author) |
|---|---|
| مؤلفون آخرون: | Yubin Zou (19832671) (author), Lifeng Huang (5211407) (author), Wenjuan Zha (2720134) (author), Qingqing Ouyang (10175801) (author), Ling Yang (34478) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Image 3_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.tif
حسب: Hua Ruan (195072)
منشور في: (2025) -
Image 4_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.tif
حسب: Hua Ruan (195072)
منشور في: (2025) -
Image 1_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.tif
حسب: Hua Ruan (195072)
منشور في: (2025) -
Table 2_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc
حسب: Hua Ruan (195072)
منشور في: (2025) -
Table 3_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc
حسب: Hua Ruan (195072)
منشور في: (2025)